• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
200 China-based Best CROs and CMOs Product Image Special Offer Sale Banner

200 China-based Best CROs and CMOs

  • ID: 799294
  • March 2009
  • Region: China
  • 252 Pages
  • JZMed Inc
Special Offer Banner
20%
OFF
Offer ends 31st Dec 2014

As Chinese pharmaceutical outsourcing industry plays more and more important roles in today’s world pharmaceutical industry, it has become increasingly urgent for the pharmaceutical and biotechnology companies worldwide that plan to outsource any part of their drug research, manufacturing and sales work to China, to have a complete collection of information with regards to the current services offered by Chinese service providers and their capabilities in each technical area. To facilitate these outsourcing companies selecting a right service partner in China whose service capability ideally matches the requirements of their to-be-outsourced projects, we extracted from our database 200 China-based, best outsourcing service providers (CROs and CMOs) and compiled them into this Company Profile.

In addition to detailed contact information, the report examined twelve areas for each service provider to measure their service capabilities. The examined categories include:

- Full description of each provider’s service scope;

- Analysis and comments of their service features and strengths;

- Evaluation of their service capability levels according to international READ MORE >

Note: Product cover images may vary from those shown

Executive Summary

PART I. Evaluation of Service Capabilities of All China-based CROs and CMOs

1. Classification and definition of service capability levels of contract pharmaceutical research and manufacturing organizations according to international standard
2. Classification and rating of China-based CROs and CMOs

PART II. Company Profile
(All companies are listed in alphabetic order)

Company Index:

1. CROs Providing Drug Discovery Service
2. CROs Providing Target Identification and Verification Service
3. CROs Providing ADME/Tox Service
4. CROs Providing Clinical Research Service
5. CROs Providing Preclinical Research Service
6. CROs Providing Custom Synthesis Service (Small Molecules up to Multi Kilo-gram Scale)
7. CROs Possessing Focused Compound Libraries
8. CROs/CMOs Providing Process R&D and Scale-up Synthesis Service
9. CROs Providing Research Service in Genomics and Proteomics
10. CMOs Providing API Manufacturing Service
11. CMOs Providing Manufacturing Service of Macro Compounds (Peptides, Proteins, Antibodies, etc.)
12. CROs/CMOs Possessing FDA/EMEA Certified cGMP Facility
13. CROs/CMOs Providing Service in Formulation and Drug Delivery Research
14. CROs Providing Drug Registration and Marketing Service
15. CROs Providing Clinical Trail and Registration Service for Medical Devices
16. CROs Providing Services in Bio-imaging, Diagnostics and Biomarkers
17. CROs Providing Bioanalytical Services
18. List of first tier players
19. List of second tier players

Appendix: About JZMed, Inc.

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

  • China Pharma Outsourcing Annual Review 2011 - Product Thumbnail Image China Pharma Outsourcing Annual Review 2011

    China Pharma Outsourcing Annual Review 2011

    • Language: English
    • 127 Pages
    • Published: February 2012
    • Region: China
    FROM
  • The New Trends of Drug Development Outsourcing in China and India 2012 - Product Thumbnail Image The New Trends of Drug Development Outsourcing in China and India 2012

    The New Trends of Drug Development Outsourcing in China and India 2012

    • Language: English
    • 215 Pages
    • Published: September 2012
    • Region: China, India
    FROM
  • The New Trends of Drug Discovery Outsourcing in China and India 2012 - Product Thumbnail Image The New Trends of Drug Discovery Outsourcing in China and India 2012

    The New Trends of Drug Discovery Outsourcing in China and India 2012

    • Language: English
    • 247 Pages
    • Published: September 2012
    • Region: China, India
    FROM
  • The New Trends of Drug R&D Outsourcing in China and India 2012 - Product Thumbnail Image The New Trends of Drug R&D Outsourcing in China and India 2012

    The New Trends of Drug R&D Outsourcing in China and India 2012

    • Language: English
    • 311 Pages
    • Published: September 2012
    • Region: China, India
    FROM
  • Chinese CRO Company Report - Pharmaron - Product Thumbnail Image Chinese CRO Company Report - Pharmaron

    Chinese CRO Company Report - Pharmaron

    • Language: English
    • 50 Pages
    • Published: November 2012
    • Region: Asia, China
    FROM
  • Chinese CRO Company Report - ShangPharma - Product Thumbnail Image Chinese CRO Company Report - ShangPharma

    Chinese CRO Company Report - ShangPharma

    • Language: English
    • 51 Pages
    • Published: November 2012
    • Region: Asia, China
    FROM
  • Chinese CRO Company Report - WuXi PharmaTech - Product Thumbnail Image Chinese CRO Company Report - WuXi PharmaTech

    Chinese CRO Company Report - WuXi PharmaTech

    • Language: English
    • 55 Pages
    • Published: November 2012
    • Region: Asia, China
    FROM
  • Biopharmaceutical Outsourcing Opportunities in China and India - Biologic Drug Discovery and Manufacturing - Product Thumbnail Image Biopharmaceutical Outsourcing Opportunities in China and India - Biologic Drug Discovery and Manufacturing
    FROM
  • Outlook of China Biopharmaceutical Outsourcing Market - Product Thumbnail Image Outlook of China Biopharmaceutical Outsourcing Market

    Outlook of China Biopharmaceutical Outsourcing Market

    • Language: English
    • 171 Pages
    • Published: July 2013
    • Region: China
    FROM
  • Pharma and Biotech M&A Trends 2009-2014 [old name Merger & Acquisition Terms and Agreements] - Product Thumbnail Image Pharma and Biotech M&A Trends 2009-2014 [old name Merger & Acquisition Terms and Agreements]

    Pharma and Biotech M&A Trends 2009-2014 [old name Merger & Acquisition Terms and Agreements]

    • Language: English
    • 1677 Pages
    • Published: July 2014
    • Region: Global
    FROM

Our Clients

Our clients' logos